Interaction of a vasopressin antagonist with vasopressin receptors in the septum of the rat brain
- 1 January 1988
- Vol. 2 (3), 205-211
- https://doi.org/10.1002/syn.890020306
Abstract
The ability of d(CH2)5‐Tyr(Me)‐arginine‐8‐vasopressin, an antagonist of peripheral pressoric (V1‐type) vasopressin receptors, to label vasopressin binding sites in the septum of the rat brain was evaluated. Using crude membrane preparations from the septum, 3H‐arginine‐8‐vasopressin (AVP) specifically labels a single class of binding sites with a Kd of 2.9nM and maximum binding site concentration of 19.8 fmole/mg protein. 3H‐Antag also labels a single class of membrane sites but with higher affinity (Kd=0.47nM) and lower capacity (10.1 fmole/mg protein) than 3H‐AVP. The rank order of potency of various competitor peptides for 3H‐AVP and 3H‐Antag binding was similar. Oxytocin was 100–1,000 fold less potent than AVP in competing for binding with both ligands. 3H‐AVP and 3H‐Antag showed similar labeling patterns when incubated with septal tissue slices. Unlabeled Antag also effectively antagonized vasopressin‐stimulated phosphatidylinositol hydrolysis in septal tissue slices.Keywords
This publication has 20 references indexed in Scilit:
- Enhanced binding of 3H-arginine8-vasopressin in the Brattleboro ratPeptides, 1986
- Topography of binding sites for neurohypophyseal hormones in rat brainEuropean Journal of Pharmacology, 1985
- Vasopressin receptor subtypes in dorsal hindbrain and renal medullaPeptides, 1985
- Central target for the behavioural effects of vasopressin neuropeptidesNature, 1984
- Characterization and localization of 3H-arginine8-vasopressin binding to rat kidney and brain tissuePeptides, 1983
- [3H]Vasopressin binding to rat hippocampal synaptic plasma membraneFEBS Letters, 1983
- Autoradiographic localization of specific binding sites for [3H][Arg8]vasopressin in the septum of the rat brain with tritium-sensitive filmEuropean Journal of Pharmacology, 1983
- [1-(.beta.-mercapto-.beta.,.beta.-cyclopentamethylenepropionic acid),2-(O-methyl)tyrosine]arginine-vasopressin and [1-(.beta.-mercapto-.beta.,.beta.-cyclopentamethylenepropionic acid)]arginine-vasopressin, two highly potent antagonists of the vasopressor response to arginine-vasopressinJournal of Medicinal Chemistry, 1980
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973